Abstract: The present disclosure relates to system architectures for real-time processing and displaying of medical imaging data with no or reduced latency. An exemplary system for generating a video of a surgery can comprise: a processor configured to execute a plurality of instructions for a machine-learning model stored on a memory and a programmable circuit communicatively coupled with the processor. The programmable circuit is programmed to: receive surgical video data comprising a current frame; provide data related to the current frame to the processor; receive overlay data generated by the machine-learning model based on a previous frame captured before the current frame; generate, by a mixer of the programmable circuit, a composite frame based on the current frame and the overlay data; and output the composite frame for display as a part of the video of the surgery.

Abstract: The present disclosure is directed to arthroscopic visualization systems and methods. The visualization system can include a camera with a fluid inflow path, wherein a proximal end of the camera is configured to fluidly connect a fluid reservoir to the fluid inflow path. The system can also include a cannula with a lumen, wherein the lumen is configured to be fluidly connected to the fluid inflow path at a distal end of the camera. In addition, the system can also include a scope, wherein the scope is configured to be connected to the distal end of the camera and a portion of the scope is configured to be inserted into the lumen of the cannula.

Abstract: Disclosed in some examples are methods, systems, and machine readable mediums for online competitive payment bidding and route selection. A payment route matching and selection service may be a network accessible computer based service which allows banks to submit payment requests that are bid on by banks that wish to handle the payment, or part of the payment. Payment requests may specify one or more desired payment properties (such as cost, speed, and the like). Bids may specify offered payment properties (e.g., cost, speed, and the like). The payment route matching and selection service may then attempt to find a payment route (including zero or more payment legs) that most closely (relative to the other routes) matches the desired payment properties of the payment request based upon the offered payment properties of the submitted bids.

Abstract: Disclosed in some examples are methods, machine readable mediums, and systems that provide for improved payment processing utilizing a trusted beneficiary identification (ID) to identify trusted beneficiaries. The trusted beneficiary ID is included in payment details by the payor and signifies that the beneficiary of the payment is trusted by virtue of a prescreening process and was found to be trustworthy. The trusted beneficiary ID speeds payment by reducing false positives on sanctions checking and also by storing a trusted beneficiary record with beneficiary information which may be utilized to reduce missing or incorrect information.

Abstract: Methods and assays for performing a lateral flow test are disclosed. A sample is applied to a receiving portion of a lateral flow device such that the sample flows to at least a first test zone and a second test zone. First and second signals levels at the first and second test zones over an assay period are monitored. If a first analyte of interest is present in the sample, the first analyte is labelled and the presence of labelled first analyte in the sample causes one of the first and second signals levels to increase during the assay period. A change between the first and second signal levels over a period of time during the assay period is monitored. The sample can be incubated prior to application to the receiving portion to provide homogeneity to labelling and therefore a substantially linear increase of the signal level at one of the test zones and a substantially constant signal level at the other one of the test zones.

Abstract: Implantable drug-doped component, e.g., a cochlear implant, including host material, a host-embedded drug, a sacrificial material integrated with the host. Sacrificial material facilitates release of drug from the component. Sacrificial material facilitates release through creation of voids in the host upon dissolution of sacrificial material upon contact with a solvent, e.g., perilymph fluid upon implant. Host can be polysiloxane, or silicone rubber. Drug can be anti-inflammatory, growth factor, antibody, anti-oxidant, antibiotic, corticosteroid. Sacrificial material can be: glucose monomer, sugar, cyclodextrin, dissolvable or resorbable at implant site, a salt, bioresorbable material, hyaluronic acid, polyurethane, polyester, polyamide, polyvinyl alcohol, polyacrylic acid. Sacrificial material can be the host, and can facilitate release of drug through changing a property of sacrificial material, e.g., by exposing component to ethanol wash.

Abstract: Embodiments are generally directed to the delivery of drugs through the use of an expandable polymeric component that is configured to swell when exposed to a recipient's bodily fluid. More specifically, in one embodiment an apparatus for implantation into a recipient comprises an expandable polymeric component and a drug delivery element that releasably carries a drug. The drug delivery element at least partially surrounds the expandable polymeric component.

Abstract: Implantable drug-doped component, e.g., a cochlear implant, including host material, a host-embedded drug, a sacrificial material integrated with the host. Sacrificial material facilitates release of drug from the component. Sacrificial material facilitates release through creation of voids in the host upon dissolution of sacrificial material upon contact with a solvent, e.g., perilymph fluid upon implant. Host can be polysiloxane, or silicone rubber. Drug can be anti-inflammatory, growth factor, antibody, anti-oxidant, antibiotic, corticosteroid. Sacrificial material can be: glucose monomer, sugar, cyclodextrin, dissolvable or resorbable at implant site, a salt, bioresorbable material, hyaluronic acid, polyurethane, polyester, polyamide, polyvinyl alcohol, polyacrylic acid. Sacrificial material can be the host, and can facilitate release of drug through changing a property of sacrificial material, e.g., by exposing component to ethanol wash.

Abstract: An implantable drug-doped component, e.g., a cochlear implant, includes host material, a host-embedded drug and a sacrificial material integrated with the host. Upon exposure of the sacrificial material to a solvent, e.g., perilymph fluid, voids in the host are created which facilitate release of the drug. The host can be, e.g., polysiloxane or silicone rubber. The sacrificial material, e.g., can be a glucose monomer, sugar, cyclodextrin, a salt, a bioresorbable material, hyaluronic acid, polyurethane, polyester, polyamide, polyvinyl alcohol, polyacrylic acid, etc. Alternatively, the sacrificial material can be the host, and can facilitate release of the drug through changing a property of the sacrificial material, e.g., by exposing the component to an ethanol wash. For a cochlear implant, e.g., the drug doped material can be applied to a non-stimulating surface of the electrode array.